(Q37783495)

23 August 2017

title

The evidence-based use of thiazide diuretics in hypertension and nephrolithiasis (English)

1 reference

https://api.crossref.org/works/10.2215/CJN.04670510

23 August 2017

The Evidence-Based Use of Thiazide Diuretics in Hypertension and Nephrolithiasis (English)

1 reference

2 July 2024

main subject

arterial hypertension

0 references

author name string

Robert F. Reilly

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20798254

2 July 2024

Aldo J. Peixoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20798254

2 July 2024

Gary V. Desir

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20798254

2 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20798254

2 July 2024

publication date

26 August 2010

1 reference

full work available at URL

23 August 2017

https://cjasn.asnjournals.org/content/clinjasn/5/10/1893.full.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20798254

http://cjasn.asnjournals.org/cgi/content/abstract/5/10/1893

2 July 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20798254

https://journals.lww.com/01277230-201010000-00026

2 July 2024

1 reference

https://api.crossref.org/works/10.2215/CJN.04670510

Clinical Journal of the American Society of Nephrology

2 July 2024

published in

1 reference

23 August 2017

volume

5

1 reference

23 August 2017

issue

10

1 reference

23 August 2017

page(s)

1893-1903

1 reference

All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective

23 August 2017

cites work

https://api.crossref.org/works/10.2215/CJN.04670510

1

1 reference

Effect of Chlorothiazide and Hydrochlorothiazide on the Excretion of Calcium in Urine

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

2

1 reference

The use of thiazides in the prevention of renal calculi

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

4

1 reference

The stone clinic effect in patients with idiopathic calcium urolithiasis

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

5

1 reference

Regression to the mean: a potential source of error in clinical pharmacological studies

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

6

1 reference

Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

8

1 reference

[The role of thiazides in the prophylaxis of recurrent calcium lithiasis]

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

9

1 reference

Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

11

1 reference

Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

12

1 reference

Do thiazides prevent recurrent idiopathic renal calcium stones?

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

14

1 reference

Double-blind study with thiazide in recurrent calcium lithiasis

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

15

1 reference

Indapamide (Natrilix): the agent of choice in the treatment of recurrent renal calculi associated with idiopathic hypercalciuria

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

17

1 reference

Hydrochlorothiazide therapy in nephrolithiasis. Effect on the urinary activity product and formation product of brushite.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

19

1 reference

The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

20

1 reference

Prevention of calcium stones with thiazides

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

21

1 reference

Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

22

1 reference

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

23

1 reference

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

24

1 reference

Treatment of mild hypertension: a five year controlled drug trial. The Oslo study

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

25

1 reference

Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

26

1 reference

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

27

1 reference

Treatment of hypertension in patients 80 years of age or older

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

28

1 reference

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

30

1 reference

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

31

1 reference

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

32

1 reference

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

34

1 reference

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

35

1 reference

The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

36

1 reference

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

37

1 reference

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

38

1 reference

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

39

1 reference

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

40

1 reference

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

41

1 reference

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

42

1 reference

Chinese Trial on Isolated Systolic Hypertension in the Elderly

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

43

1 reference

Shanghai trial of nifedipine in the elderly (STONE)

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

44

1 reference

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

45

1 reference

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

46

1 reference

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

47

1 reference

Hydrochlorothiazide versus chlorthalidone in the management of hypertension

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

48

1 reference

Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

49

1 reference

Using diuretics in practice--one opinion

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

50

1 reference

Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

51

1 reference

Use of diuretics in patients with hypertension

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

52

1 reference

A double-blind study of chlorthalidone and hydrochlorothiazide in an outpatient population of moderate hypertensives

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

53

1 reference

Comparison of indapamide and low-dose hydrochlorothiazide monotherapy in black patients with mild to moderate hypertension

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

54

1 reference

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

55

1 reference

Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

56

1 reference

Indapamide in the treatment of essential arterial hypertension: results of a controlled study

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

57

1 reference

Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP)

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

58

1 reference

Is the development of diabetes with antihypertensive therapy a problem?--Pro

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

59

1 reference

Diuretics and beta-blockers: is there a risk for dyslipidemia?

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

61

1 reference

Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

62

1 reference

Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based low-dose diuretic therapies

2 July 2024

https://api.crossref.org/works/10.2215/CJN.04670510

63

1 reference

2 July 2024

Identifiers

DOI

10.2215/CJN.04670510

1 reference

23 August 2017

1 reference